Stocks TelegraphStocks Telegraph
Stock Ideas

IRD Stock Performance and Key Statistics

NASDAQ : IRD

Opus Genetics

$4.75
0.24+5.32%
At Close 4:00 PM

stock performance chart

IRD Fundamental Analysis

Based on recent data, Opus Genetics, Inc. (IRD) shows an Average True Range (ATR) of 0.25 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 912.74K, indicating liquidity. These fundamental metrics provide insight into IRD's underlying financial health and market activity.

ATR0.25
Enterprise Value-
Avg Vol (3 Months)912.74K
Avg Vol (10 Days)703.89K

IRD Technical Analysis Indicators

Opus Genetics, Inc. (IRD) technical indicators as of March 26, 2026: the SMA 20 is 13.28%, SMA 50 at 39.51%, and SMA 200 at 106.75%. The RSI 14 value is 62.44, suggesting its current momentum. These technical analysis signals help assess IRD's price trends and potential future movements.

SMA 2013.28%
SMA 5039.51%
SMA 200106.75%
RSI 1462.44

IRD Stock Performance Overview

Opus Genetics, Inc. (IRD) stock performance overview as of March 26, 2026: The 52-week high is $5.3 (currently -9.46% below), and the 52-week low is $0.65 (currently 452.31% above). Over the past year, IRD's performance is 94.83%, compared to the S&P 500's 14.34% change.

52-Week High5.3
52-Week High Chg-9.46%
52-Week Low0.65
52-Week Low Chg+452.31%
S&P 500 52-Week Chg14.34%

Opus Genetics, Inc. (IRD) Historical Stock Performance

According to market data, Opus Genetics, Inc. (IRD) stock's recent performance metrics show that over the last month, IRD is 11.88%, with a Year-to-Date (YTD) performance of 12.44%. Over the past year, the stock has seen a 94.83% change. These figures summarize IRD's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High4.795.35.35.35.35.3
Low4.323.291.881.420.651.88
Performance+10.24%+11.88%+20.86%+89.92%+94.83%+12.44%

Industry Analysis and Valuation

According to current financial data, IRD stock's P/E (TTM) ratio is -58.25, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for IRD, including P/S (23.27), P/B (188.21), and P/FCF (-9.37), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationIRDSector MedianIndustry AvgS&P 500
P/E (TTM)-58.25-1.23-5.1632.59
P/S (TTM)23.273.71464.925.98
P/B (TTM)188.217.624.774.62
P/FCF (TTM)-9.3772.79-221.0332.15

Frequently Asked Questions

How is IRD price-to-earnings ratio currently?
IRD has a current P/E ratio of -58.25
How are IRD's price-to-sale and price-to-book ratios?
The IRD stock has a trailing twelve month price-to sales (P/S) ratio of 23.27 while its price-to-book (P/B) value is 188.21.
Is Opus Genetics, Inc.'s price-to-cashflow ratio high or low?
IRD's price-to-free-cashflow (P/FCF) ratio is -9.37, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for IRD?
Based on IRD's recent bid, its distance from 20 days simple moving average is 13.28%. It is 39.51% apart from 50 days simple moving average, and it is 106.75% apart from 200 days simple moving average.
What is the 52-week price range for IRD?
The 52-week high for IRD is $5.30 which is -9.46% away from the current price level whereas the distance of that from the 52-week low of $0.65 stands at 452.31%.
An overview of IRD's stock performance: how did it fare?
The performance of IRD stock was not encouraging with most of its significant price indicators in green. Opus Genetics, Inc.(NASDAQ: IRD) shares have moved upward +5.32% or $0.24 in the latest trading session and have gained 12.44% year-to-date (YTD). The stock has gained nearly 94.83% over the past year. After moving 20.86% over the trailing 3-month period, the stock is 89.92% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 10.24% a week and 11.88% a month.
What is IRD's 14-day relative strength index (RSI)?
The current 14-day RSI for IRD stock is 62.44. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For IRD, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Opus Genetics, Inc. (IRD) has a 14-day ATR of 0.25.
What is IRD's current enterprise value?
After closing at $4.51 with 71.15M of its shares outstanding, the current enterprise value of IRD is roughly -.
Over the past year, how has the stock price of IRD changed?
Opus Genetics, Inc. (NASDAQ: IRD) is up 94.83% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 14.34%. IRD stock price is also up 12.44% on its value in year-to-date trading.
What is the average trading volume for IRD shares?
The number outstanding shares of IRD is 71.15M, and of these 46.27% shares are freely available for trading. On average, IRD stock has traded 703.89K shares per day for the past 10 days. A total of 381.34K shares changed hands during the last trading session with the average session volume of 939.85K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph